Keyphrases
Matrix Metalloproteinases
100%
Advanced Glycation End Products
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Vascular Complications
30%
N-carboxymethyllysine
20%
MG-H1
20%
Matrix metalloproteinase-1 (MMP-1)
20%
Lysine
20%
Pentosidine
20%
Matrix Metalloproteinase Inhibitors
20%
Extracellular Matrix Remodeling
10%
Protein Binding
10%
Type 1 Diabetic
10%
Linear Regression Analysis
10%
Diabetes Duration
10%
Non-associated
10%
Serum Levels
10%
Hydro
10%
Potential Confounders
10%
Matrix metalloproteinase-9 (MMP-9)
10%
Matrix metalloproteinase-3 (MMP-3)
10%
Hemoglobin A1c (HbA1c)
10%
AIMS™
10%
Matrix metalloproteinase-2 (MMP-2)
10%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Matrix Metalloproteinase
100%
Advanced Glycation End-Product
100%
Tissue Inhibitor of Metalloproteinase 1
87%
Metalloprotease Inhibitor
37%
Lysine
25%
Pentosidine
25%
Interstitial Collagenase
25%
6 N Carboxymethyllysine
25%
Gelatinase A
12%
Gelatinase B
12%
Hemoglobin A1c
12%
Patient with Type 1 Diabetes
12%
Linear Regression Analysis
12%
Extracellular Matrix
12%
Diabetes Mellitus
12%
Stromelysin
12%
Diabetes
12%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Glycation End Product
100%
Matrix Metalloproteinase
100%
Insulin Dependent Diabetes Mellitus
100%
Tissue Inhibitor of Metalloproteinase 1
87%
Tissue Inhibitor of Metalloproteinase
37%
Lysine
25%
Pentosidine
25%
Interstitial Collagenase
25%
6 N Carboxymethyllysine
25%
Hemoglobin A1c
12%
Gelatinase B
12%
Stromelysin
12%
Gelatinase A
12%
Diabetes Mellitus
12%
Neuroscience
Matrix Metalloproteinase
100%
Metalloprotease Inhibitor
100%
Advanced Glycation End Product
100%
Pentosidine
20%
Lysine
20%
Interstitial Collagenase
20%
N(6)-Carboxymethyllysine
20%
MMP9
10%
MMP2
10%
Diabetes Mellitus
10%
Stromelysin
10%
Hemoglobin A1c
10%
Extracellular Matrix
10%
Immunology and Microbiology
Glycation
100%
Lysine
50%
Extracellular Matrix
12%
Blood Level
12%